RefuelBio ApS
Private limited companyCVR 44960907FrederiksbergActive
RefuelBio ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2024. The company made a loss in both 2024 and 2025, most recently DKK 10.5m. The company is new and has been registered for 2 years. Equity grew to DKK 20.6m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 6.2m to DKK 10.5m (2024 → 2025).
- Equity rose 135% (2024 → 2025), to DKK 20.6m.
Employees
- 2 more employees than a year earlier: 3 (07/2026) against 1 (07/2025).
Management and owners, last 24 months
- New in management: Satvik Dasariraju (board member, 12/08/2025), Alexander James Colville (board member, 12/08/2025) and Thomas Gundelund Rasmussen (ceo, 01/09/2025) (+4).
- Stepped down: Søren Sylvester Skjærbæk (ceo, 31/08/2025), Emmanuelle Coutanceau (chair of the board, 20/10/2025) and Marie Allen Schroeder (board member, 21/10/2025).
- New owners registered: Novo Holdings A/S (23/06/2025), Age1 Fund I, LP (24/04/2026) and Novo Holdings A/S (28/11/2024) (+3).
- No longer registered as owner: Marcia Haigis (27/11/2024), Novo Holdings A/S (27/11/2024) and Novo Holdings A/S (22/06/2025) (+3).
Registrations, last 24 months
- 11/08/2026: Share capital changed from 818,584 DKK to 1,031,096 DKK
- 24/04/2026: Share capital changed from 394,272 DKK to 818,584 DKK
- 12/08/2025: Share capital changed from 323,435 DKK to 394,272 DKK
- 23/06/2025: Share capital changed from 181,760 DKK to 323,435 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
- 28/11/2024: Share capital changed from 110,880 DKK to 181,760 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | 0 | not stated | – |
| Gross profit | −7,661 | −13,452 | −75.6% |
| Operating profit (EBIT) | −7,994 | −14,171 | −77.3% |
| Profit before tax | −7,841 | −13,736 | −75.2% |
| Net profit | −6,198 | −10,527 | −69.9% |
| Total assets | 9,161 | 23,134 | +152.5% |
| Equity | 8,751 | 20,574 | +135.1% |
| Liabilities | 410 | 2,560 | +524.3% |
| Cash and cash equivalents | 7,250 | 19,375 | +167.3% |
| Average number of employees | – | 1 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 18/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/07/2024 – 31/12/2024 | 24/02/2025 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,673of 69,742 Better than 0% | No. 5,685of 69,964 Better than 92% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 313of 323 Better than 3% | No. 37of 329 Better than 89% |
| Companies that are founded within the last five years16,675 companies in the comparison | No. 16,599of 16,627 Better than 0% | No. 557of 16,674 Better than 97% |
| All companies of type ApS66,508 companies in the comparison | No. 66,311of 66,379 Better than 0% | No. 4,154of 66,505 Better than 94% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- RefuelBio ApS−DKK 13.5m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- RefuelBio ApS−DKK 10.5m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- RefuelBio ApSDKK 20.6m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- RefuelBio ApS3
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Novo Holdings A/S66.67%
- Age1 Fund I, LP25%
Management
7 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Thomas Gundelund Rasmussen | CEO | 01/09/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Satvik Dasariraju | Board member | 12/08/2025 |
| Alexander James Colville | Board member | 12/08/2025 |
| Emmanuelle Coutanceau | Board member | 21/10/2025 |
| Gabor Gyulveszi | Board member | 21/10/2025 |
| Lloyd Berl Klickstein | Chair of the board | 21/10/2025 |
| Jonathan David McNeill | Board member | 10/02/2026 |
- Founders
- Marcia Haigis
Former management (3)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Søren Sylvester Skjærbæk | CEO | 01/07/2024 | 31/08/2025 |
| Emmanuelle Coutanceau | Chair of the board | 16/07/2024 | 20/10/2025 |
| Marie Allen Schroeder | Board member | 16/07/2024 | 21/10/2025 |
Signing rule: Selskabet tegnes af en direktør i forening med formanden for bestyrelsen eller af den samlede bestyrelse
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| RefuelBio ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 3 | 1030521117 |
Purpose
Selskabets formål er forskning, udvikling og kommercialisering af medicinske produkter samt aktiviteter, der efter ledelsens skøn er forbundet dermed.
The purpose is quoted from the register in Danish.
Changes year by year
38 registered events20267 changescapital 2 · accounts 1 · ownership 3 · management 1
- CapitalShare capital changed from 818,584 DKK to 1,031,096 DKK
- AccountsAnnual report for 2025 published
- CapitalShare capital changed from 394,272 DKK to 818,584 DKK
- OwnershipAge1 Fund I, LP registered as owner (25%)
- OwnershipMarcia Haigis is no longer registered as owner
- OwnershipAge1 Fund I, LP is no longer registered as owner
- ManagementJonathan David McNeill appointed board member
202518 changesmanagement 9 · capital 2 · ownership 5 · accounts 1 · industry 1
- ManagementEmmanuelle Coutanceau appointed board member
- ManagementLloyd Berl Klickstein appointed chair of the board
- ManagementGabor Gyulveszi appointed board member
- ManagementMarie Allen Schroeder stepped down as board member
- ManagementEmmanuelle Coutanceau stepped down as chair of the board
- ManagementThomas Gundelund Rasmussen appointed ceo
- ManagementSøren Sylvester Skjærbæk stepped down as ceo
- CapitalShare capital changed from 323,435 DKK to 394,272 DKK
- ManagementAlexander James Colville appointed board member
- ManagementSatvik Dasariraju appointed board member
- OwnershipAge1 Fund I, LP registered as owner (15%)
- CapitalShare capital changed from 181,760 DKK to 323,435 DKK
- OwnershipMarcia Haigis registered as owner (10%)
- OwnershipNovo Holdings A/S registered as owner (66.67%)
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipMarcia Haigis is no longer registered as owner
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202413 changescapital 2 · ownership 6 · address 1 · management 3 · founded 1
- CapitalShare capital changed from 110,880 DKK to 181,760 DKK
- OwnershipNovo Holdings A/S registered as owner (66.67%)
- OwnershipMarcia Haigis registered as owner (20%)
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipMarcia Haigis is no longer registered as owner
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
- CapitalShare capital changed from 40,000 DKK to 110,880 DKK
- ManagementMarie Allen Schroeder appointed board member
- ManagementEmmanuelle Coutanceau appointed chair of the board
- OwnershipNovo Holdings A/S registered as owner (50%)
- FoundedRegistered as RefuelBio ApS
- ManagementSøren Sylvester Skjærbæk appointed ceo
- OwnershipMarcia Haigis registered as owner (33.33%)
Related companies
Same industry in Frederiksberg
- Adcendo ApS49 employees
- Orbis Medicines ApS32 employees
- Minervax ApS28 employees
- Inprother ApS18 employees
- Acesion Pharma ApS16 employees
- Kost Studio ApS11 employees
Same people in management
- Actas A/Svia Søren Sylvester Skjærbæk
- NRGI A.m.b.a.via Søren Sylvester Skjærbæk
- Orbis Medicines ApSvia Søren Sylvester Skjærbæk
- Minervax ApSvia Emmanuelle Coutanceau
- Freya Biosciences ApSvia Thomas Gundelund Rasmussen
- de novo foundry ApSvia Emmanuelle Coutanceau
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.